161 related articles for article (PubMed ID: 17354630)
1. [Intermittent claudication in Italy. The Peripheral Arteriopathy and Cardiovascular Events (PACE) study].
Brevetti G; Oliva G; Sirico G; Giugliano G; Chiariello M
G Ital Cardiol (Rome); 2007 Jan; 8(1):34-42. PubMed ID: 17354630
[TBL] [Abstract][Full Text] [Related]
2. Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study.
Brevetti G; Schiano V; Verdoliva S; Silvestro A; Sirico G; De Maio J; Lanero S; Chiariello M
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):608-13. PubMed ID: 16858240
[TBL] [Abstract][Full Text] [Related]
3. Functional status measured by walking impairment questionnaire and cardiovascular risk prediction in peripheral arterial disease: results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study.
Schiano V; Brevetti G; Sirico G; Silvestro A; Giugliano G; Chiariello M
Vasc Med; 2006 Nov; 11(3):147-54. PubMed ID: 17288120
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy.
Brevetti G; Oliva G; Silvestro A; Scopacasa F; Chiariello M;
Atherosclerosis; 2004 Jul; 175(1):131-8. PubMed ID: 15186957
[TBL] [Abstract][Full Text] [Related]
5. Differences between women and men with intermittent claudication: a cross-sectional study.
Lozano FS; González-Porras JR; March JR; Carrasco E; Lobos JM;
J Womens Health (Larchmt); 2014 Oct; 23(10):834-41. PubMed ID: 25238019
[TBL] [Abstract][Full Text] [Related]
6. Contribution of cardiovascular risk factors to coronary risk in patients with intermittent claudication in the PRIME Cohort Study of European men.
Tilloy E; Montaye M; Kee F; Bingham A; Arveiler D; Ruidavets JB; Evans A; Haas B; Ferrières J; Ducimetière P; Amouyel P; Dallongeville J
Atherosclerosis; 2009 Oct; 206(2):563-8. PubMed ID: 19403136
[TBL] [Abstract][Full Text] [Related]
7. [Asymptomatic arteriopathy of the lower limbs. Prevalence and risk factors in a population of southern Italy].
Pujia A; Gnasso A; Mancuso G; Spagnuolo M; Cosco C; Cortese C; Colonna A; Mattioli PL
Minerva Cardioangiol; 1993 Apr; 41(4):133-8. PubMed ID: 8332269
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk.
Ramos R; Quesada M; Solanas P; Subirana I; Sala J; Vila J; Masiá R; Cerezo C; Elosua R; Grau M; Cordón F; Juvinyà D; Fitó M; Isabel Covas M; Clarà A; Angel Muñoz M; Marrugat J;
Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):305-11. PubMed ID: 19515589
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of peripheral arterial disease.
Balkau B; Vray M; Eschwege E
J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S8-16. PubMed ID: 7517479
[TBL] [Abstract][Full Text] [Related]
10. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population.
Leng GC; Lee AJ; Fowkes FG; Whiteman M; Dunbar J; Housley E; Ruckley CV
Int J Epidemiol; 1996 Dec; 25(6):1172-81. PubMed ID: 9027521
[TBL] [Abstract][Full Text] [Related]
11. [The natural history of peripheral arteriopathy].
Valente M; Ponte E
Minerva Cardioangiol; 1993 May; 41(5):167-72. PubMed ID: 8355855
[TBL] [Abstract][Full Text] [Related]
12. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population.
Fowkes FG; Housley E; Cawood EH; Macintyre CC; Ruckley CV; Prescott RJ
Int J Epidemiol; 1991 Jun; 20(2):384-92. PubMed ID: 1917239
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of metabolic syndrome in patients with intermittent claudication and its correlation with the segment of arterial obstruction.
Zerati AE; Wolosker N; Ayzin Rosoky RM; Fernandes Saes G; Ragazzo L; Puech-Leão P
Angiology; 2010 Nov; 61(8):784-8. PubMed ID: 20395234
[TBL] [Abstract][Full Text] [Related]
14. Depressive symptoms in peripheral arterial disease: a follow-up study on prevalence, stability, and risk factors.
Smolderen KG; Aquarius AE; de Vries J; Smith OR; Hamming JF; Denollet J
J Affect Disord; 2008 Sep; 110(1-2):27-35. PubMed ID: 18237784
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic peripheral arterial disease: the value of a validated questionnaire and a clinical decision rule.
Bendermacher BL; Teijink JA; Willigendael EM; Bartelink ML; Büller HR; Peters RJ; Boiten J; Langenberg M; Prins MH
Br J Gen Pract; 2006 Dec; 56(533):932-7. PubMed ID: 17132381
[TBL] [Abstract][Full Text] [Related]
16. Completing the audit cycle: comparison of cardiac risk factor management in patients with intermittent claudication in two time periods.
Wilson AM; Bachoo P; Mackay IA; Cassar K; Brittenden J
Eur J Vasc Endovasc Surg; 2007 Jun; 33(6):710-4. PubMed ID: 17336105
[TBL] [Abstract][Full Text] [Related]
17. The impact of walking impairment, cardiovascular risk factors, and comorbidity on quality of life in patients with intermittent claudication.
Breek JC; Hamming JF; De Vries J; van Berge Henegouwen DP; van Heck GL
J Vasc Surg; 2002 Jul; 36(1):94-9. PubMed ID: 12096264
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of (a)symptomatic peripheral arterial disease; the additional value of ankle-brachial index on cardiovascular risk stratification.
van Kuijk JP; Flu WJ; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2009 Sep; 38(3):312-3. PubMed ID: 19524459
[No Abstract] [Full Text] [Related]
19. Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease.
Myers SA; Johanning JM; Stergiou N; Lynch TG; Longo GM; Pipinos II
J Vasc Surg; 2008 Mar; 47(3):550-555. PubMed ID: 18207355
[TBL] [Abstract][Full Text] [Related]
20. Femoral plaque echogenicity and cardiovascular risk in claudicants.
Schiano V; Sirico G; Giugliano G; Laurenzano E; Brevetti L; Perrino C; Brevetti G; Esposito G
JACC Cardiovasc Imaging; 2012 Apr; 5(4):348-57. PubMed ID: 22498323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
